Pharmaceutical CDMO Market Size (USD 250.07 M) by 2032 By Types (Active Pharmaceutical Ingredient (API) Manufacturing, Finished Dosage Formulation (FDF) Development and Manufacturing, Secondary Packaging), By Applications Covered (Small & Mid-Size Pharma Companies, Generic Pharmaceutical Companies, Big Pharma Companies, Others) and Regional Forecast to 2032

Detailed TOC of Global Pharmaceutical CDMO Industry Research Report, In-depth Analysis of Current Status and Outlook of Key Countries 2023-2031

Table of Content

1 Pharmaceutical CDMO Market Overview
1.1 Product Overview and Scope of Pharmaceutical CDMO Market
1.2 Pharmaceutical CDMO Market Segment by Type
1.2.1 Global Pharmaceutical CDMO Market Sales Volume and CAGR (%) Comparison by Type (2017-2031)
1.3 Global Pharmaceutical CDMO Market Segment by Application
1.3.1 Pharmaceutical CDMO Market Consumption (Sales Volume) Comparison by Application (2017-2031)
1.4 Global Pharmaceutical CDMO Market, Region Wise (2017-2031)
1.4.1 Global Pharmaceutical CDMO Market Size (Revenue) and CAGR (%) Comparison by Region (2017-2031)
1.4.2 United States Pharmaceutical CDMO Market Status and Prospect (2017-2031)
1.4.3 Europe Pharmaceutical CDMO Market Status and Prospect (2017-2031)
1.4.4 China Pharmaceutical CDMO Market Status and Prospect (2017-2031)
1.4.5 Japan Pharmaceutical CDMO Market Status and Prospect (2017-2031)
1.4.6 India Pharmaceutical CDMO Market Status and Prospect (2017-2031)
1.4.7 Southeast Asia Pharmaceutical CDMO Market Status and Prospect (2017-2031)
1.4.8 Latin America Pharmaceutical CDMO Market Status and Prospect (2017-2031)
1.4.9 Middle East and Africa Pharmaceutical CDMO Market Status and Prospect (2017-2031)
1.5 Global Market Size of Pharmaceutical CDMO (2017-2031)
1.5.1 Global Pharmaceutical CDMO Market Revenue Status and Outlook (2017-2031)
1.5.2 Global Pharmaceutical CDMO Market Sales Volume Status and Outlook (2017-2031)
1.6 Global Macroeconomic Analysis
1.7 The impact of the Russia-Ukraine war on the Pharmaceutical CDMO Market

2 Industry Outlook
2.1 Pharmaceutical CDMO Industry Technology Status and Trends
2.2 Industry Entry Barriers
2.2.1 Analysis of Financial Barriers
2.2.2 Analysis of Technical Barriers
2.2.3 Analysis of Talent Barriers
2.2.4 Analysis of Brand Barrier
2.3 Pharmaceutical CDMO Market Drivers Analysis
2.4 Pharmaceutical CDMO Market Challenges Analysis
2.5 Emerging Market Trends
2.6 Consumer Preference Analysis
2.7 Pharmaceutical CDMO Industry Development Trends under COVID-19 Outbreak
2.7.1 Global COVID-19 Status Overview
2.7.2 Influence of COVID-19 Outbreak on Pharmaceutical CDMO Industry Development

3 Global Pharmaceutical CDMO Market Landscape by Player
3.1 Global Pharmaceutical CDMO Sales Volume and Share by Player (2017-2022)
3.2 Global Pharmaceutical CDMO Revenue and Market Share by Player (2017-2022)
3.3 Global Pharmaceutical CDMO Average Price by Player (2017-2022)
3.4 Global Pharmaceutical CDMO Gross Margin by Player (2017-2022)
3.5 Pharmaceutical CDMO Market Competitive Situation and Trends
3.5.1 Pharmaceutical CDMO Market Concentration Rate
3.5.2 Pharmaceutical CDMO Market Share of Top 3 and Top 6 Players
3.5.3 Mergers & Acquisitions, Expansion

4 Global Pharmaceutical CDMO Sales Volume and Revenue Region Wise (2017-2022)
4.1 Global Pharmaceutical CDMO Sales Volume and Market Share, Region Wise (2017-2022)
4.2 Global Pharmaceutical CDMO Revenue and Market Share, Region Wise (2017-2022)
4.3 Global Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4 United States Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.4.1 United States Pharmaceutical CDMO Market Under COVID-19
4.5 Europe Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.5.1 Europe Pharmaceutical CDMO Market Under COVID-19
4.6 China Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.6.1 China Pharmaceutical CDMO Market Under COVID-19
4.7 Japan Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.7.1 Japan Pharmaceutical CDMO Market Under COVID-19
4.8 India Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.8.1 India Pharmaceutical CDMO Market Under COVID-19
4.9 Southeast Asia Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.9.1 Southeast Asia Pharmaceutical CDMO Market Under COVID-19
4.10 Latin America Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.10.1 Latin America Pharmaceutical CDMO Market Under COVID-19
4.11 Middle East and Africa Pharmaceutical CDMO Sales Volume, Revenue, Price and Gross Margin (2017-2022)
4.11.1 Middle East and Africa Pharmaceutical CDMO Market Under COVID-19

5 Global Pharmaceutical CDMO Sales Volume, Revenue, Price Trend by Type
5.1 Global Pharmaceutical CDMO Sales Volume and Market Share by Type (2017-2022)
5.2 Global Pharmaceutical CDMO Revenue and Market Share by Type (2017-2022)
5.3 Global Pharmaceutical CDMO Price by Type (2017-2022)
5.4 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate by Type (2017-2022)
5.4.1 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing (2017-2022)
5.4.2 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate of Finished Dosage Formulation (FDF) Development and Manufacturing (2017-2022)
5.4.3 Global Pharmaceutical CDMO Sales Volume, Revenue and Growth Rate of Secondary Packaging (2017-2022)

6 Global Pharmaceutical CDMO Market Analysis by Application
6.1 Global Pharmaceutical CDMO Consumption and Market Share by Application (2017-2022)
6.2 Global Pharmaceutical CDMO Consumption Revenue and Market Share by Application (2017-2022)
6.3 Global Pharmaceutical CDMO Consumption and Growth Rate by Application (2017-2022)
6.3.1 Global Pharmaceutical CDMO Consumption and Growth Rate of Small & Mid-Size Pharma Companies (2017-2022)
6.3.2 Global Pharmaceutical CDMO Consumption and Growth Rate of Generic Pharmaceutical Companies (2017-2022)
6.3.3 Global Pharmaceutical CDMO Consumption and Growth Rate of Big Pharma Companies (2017-2022)
6.3.4 Global Pharmaceutical CDMO Consumption and Growth Rate of Others (2017-2022)

7 Global Pharmaceutical CDMO Market Forecast (2022-2031)
7.1 Global Pharmaceutical CDMO Sales Volume, Revenue Forecast (2022-2031)
7.1.1 Global Pharmaceutical CDMO Sales Volume and Growth Rate Forecast (2022-2031)
7.1.2 Global Pharmaceutical CDMO Revenue and Growth Rate Forecast (2022-2031)
7.1.3 Global Pharmaceutical CDMO Price and Trend Forecast (2022-2031)
7.2 Global Pharmaceutical CDMO Sales Volume and Revenue Forecast, Region Wise (2022-2031)
7.2.1 United States Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.2 Europe Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.3 China Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.4 Japan Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.5 India Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.6 Southeast Asia Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.7 Latin America Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2031)
7.2.8 Middle East and Africa Pharmaceutical CDMO Sales Volume and Revenue Forecast (2022-2031)
7.3 Global Pharmaceutical CDMO Sales Volume, Revenue and Price Forecast by Type (2022-2031)
7.3.1 Global Pharmaceutical CDMO Revenue and Growth Rate of Active Pharmaceutical Ingredient (API) Manufacturing (2022-2031)
7.3.2 Global Pharmaceutical CDMO Revenue and Growth Rate of Finished Dosage Formulation (FDF) Development and Manufacturing (2022-2031)
7.3.3 Global Pharmaceutical CDMO Revenue and Growth Rate of Secondary Packaging (2022-2031)
7.4 Global Pharmaceutical CDMO Consumption Forecast by Application (2022-2031)
7.4.1 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Small & Mid-Size Pharma Companies(2022-2031)
7.4.2 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Generic Pharmaceutical Companies(2022-2031)
7.4.3 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Big Pharma Companies(2022-2031)
7.4.4 Global Pharmaceutical CDMO Consumption Value and Growth Rate of Others(2022-2031)
7.5 Pharmaceutical CDMO Market Forecast Under COVID-19

8 Pharmaceutical CDMO Market Upstream and Downstream Analysis
8.1 Pharmaceutical CDMO Industrial Chain Analysis
8.2 Key Raw Materials Suppliers and Price Analysis
8.3 Manufacturing Cost Structure Analysis
8.3.1 Labor Cost Analysis
8.3.2 Energy Costs Analysis
8.3.3 R&D Costs Analysis
8.4 Alternative Product Analysis
8.5 Major Distributors of Pharmaceutical CDMO Analysis
8.6 Major Downstream Buyers of Pharmaceutical CDMO Analysis
8.7 Impact of COVID-19 and the Russia-Ukraine war on the Upstream and Downstream in the Pharmaceutical CDMO Industry

9 Players Profiles
9.1 IQVIA Holdings Inc.
9.1.1 IQVIA Holdings Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.1.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.1.3 IQVIA Holdings Inc. Market Performance (2017-2022)
9.1.4 Recent Development
9.1.5 SWOT Analysis
9.2 Syneos Health Inc.
9.2.1 Syneos Health Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.2.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.2.3 Syneos Health Inc. Market Performance (2017-2022)
9.2.4 Recent Development
9.2.5 SWOT Analysis
9.3 Pharmaceutical Product Development LLC
9.3.1 Pharmaceutical Product Development LLC Basic Information, Manufacturing Base, Sales Region and Competitors
9.3.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.3.3 Pharmaceutical Product Development LLC Market Performance (2017-2022)
9.3.4 Recent Development
9.3.5 SWOT Analysis
9.4 Novotech Pty Ltd
9.4.1 Novotech Pty Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.4.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.4.3 Novotech Pty Ltd Market Performance (2017-2022)
9.4.4 Recent Development
9.4.5 SWOT Analysis
9.5 WuXi AppTec Inc.
9.5.1 WuXi AppTec Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.5.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.5.3 WuXi AppTec Inc. Market Performance (2017-2022)
9.5.4 Recent Development
9.5.5 SWOT Analysis
9.6 Covance Inc.
9.6.1 Covance Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.6.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.6.3 Covance Inc. Market Performance (2017-2022)
9.6.4 Recent Development
9.6.5 SWOT Analysis
9.7 Hangzhou Tigermed Consulting Co. Ltd
9.7.1 Hangzhou Tigermed Consulting Co. Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.7.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.7.3 Hangzhou Tigermed Consulting Co. Ltd Market Performance (2017-2022)
9.7.4 Recent Development
9.7.5 SWOT Analysis
9.8 Sagimet Biosciences (3V Biosciences Inc.)
9.8.1 Sagimet Biosciences (3V Biosciences Inc.) Basic Information, Manufacturing Base, Sales Region and Competitors
9.8.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.8.3 Sagimet Biosciences (3V Biosciences Inc.) Market Performance (2017-2022)
9.8.4 Recent Development
9.8.5 SWOT Analysis
9.9 SGS Life Science Services SA
9.9.1 SGS Life Science Services SA Basic Information, Manufacturing Base, Sales Region and Competitors
9.9.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.9.3 SGS Life Science Services SA Market Performance (2017-2022)
9.9.4 Recent Development
9.9.5 SWOT Analysis
9.10 Quanticate Ltd
9.10.1 Quanticate Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.10.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.10.3 Quanticate Ltd Market Performance (2017-2022)
9.10.4 Recent Development
9.10.5 SWOT Analysis
9.11 PRA Health Sciences Inc.
9.11.1 PRA Health Sciences Inc. Basic Information, Manufacturing Base, Sales Region and Competitors
9.11.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.11.3 PRA Health Sciences Inc. Market Performance (2017-2022)
9.11.4 Recent Development
9.11.5 SWOT Analysis
9.12 Samsung Bioepis Co. Ltd
9.12.1 Samsung Bioepis Co. Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.12.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.12.3 Samsung Bioepis Co. Ltd Market Performance (2017-2022)
9.12.4 Recent Development
9.12.5 SWOT Analysis
9.13 PAREXEL International Corporation
9.13.1 PAREXEL International Corporation Basic Information, Manufacturing Base, Sales Region and Competitors
9.13.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.13.3 PAREXEL International Corporation Market Performance (2017-2022)
9.13.4 Recent Development
9.13.5 SWOT Analysis
9.14 LSK Global Pharma Service Co. Ltd
9.14.1 LSK Global Pharma Service Co. Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.14.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.14.3 LSK Global Pharma Service Co. Ltd Market Performance (2017-2022)
9.14.4 Recent Development
9.14.5 SWOT Analysis
9.15 CMIC Holdings Co. Ltd
9.15.1 CMIC Holdings Co. Ltd Basic Information, Manufacturing Base, Sales Region and Competitors
9.15.2 Pharmaceutical CDMO Product Profiles, Application and Specification
9.15.3 CMIC Holdings Co. Ltd Market Performance (2017-2022)
9.15.4 Recent Development
9.15.5 SWOT Analysis

10 Research Findings and Conclusion

11 Appendix
11.1 Methodology
11.2 Research Data Source